NCT00095875 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 70
- group Id
- BG001
- value
- 75
- group Id
- BG002
- value
- 145
- units
- Participants
- groups
- description
- Patients receive induction chemotherapy comprising docetaxel, cisplatin, and fluorouracil. Treatment repeats every 21 days for 3 courses. Patients achieving a pathologic complete response at the primary site and a clinical complete response in the neck then receive carboplatin once weekly and undergo concurrent radiotherapy once daily, 5 days a week, for 7 weeks. Patients with a partial response at the primary site (i.e., positive biopsy), stable disease, or radiographic evidence of persistent disease in the neck receive docetaxel once weekly for 4 weeks and undergo concurrent radiotherapy once or twice daily, 5 days a week, for 6 weeks. cisplatin : Given IV radiation therapy : Patients undergo radiation therapy once or twice daily, 5 days a week, for up to 7 weeks carboplatin : Given IV fluorouracil : Given IV docetaxel : Given IV
- id
- BG000
- title
- Arm I
- description
- Patients receive cisplatin IV on weeks 1 and 4 and undergo concurrent radiotherapy once or twice daily, 5 days a week, for 6 weeks. cisplatin : Given IV radiation therapy : Patients undergo radiation therapy once or twice daily, 5 days a week, for up to 7 weeks
- id
- BG001
- title
- Arm II
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 59
- group Id
- BG001
- value
- 66
- group Id
- BG002
- value
- 125
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 20
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9
- value
- 55
- group Id
- BG001
- spread
- 8
- value
- 54
- group Id
- BG002
- spread
- 8.4
- value
- 55
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 18
- title
- Female
- measurements
- group Id
- BG000
- value
- 64
- group Id
- BG001
- value
- 63
- group Id
- BG002
- value
- 127
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 138
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 7
- title
- Germany
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 70
- group Id
- BG001
- value
- 75
- group Id
- BG002
- value
- 145
- units
- Participants
- groups
- description
- Patients receive induction chemotherapy comprising docetaxel, cisplatin, and fluorouracil. Treatment repeats every 21 days for 3 courses. Patients achieving a pathologic complete response at the primary site and a clinical complete response in the neck then receive carboplatin once weekly and undergo concurrent radiotherapy once daily, 5 days a week, for 7 weeks. Patients with a partial response at the primary site (i.e., positive biopsy), stable disease, or radiographic evidence of persistent disease in the neck receive docetaxel once weekly for 4 weeks and undergo concurrent radiotherapy once or twice daily, 5 days a week, for 6 weeks. cisplatin : Given IV radiation therapy : Patients undergo radiation therapy once or twice daily, 5 days a week, for up to 7 weeks carboplatin : Given IV fluorouracil : Given IV docetaxel : Given IV
- id
- BG000
- title
- Arm I
- description
- Patients receive cisplatin IV on weeks 1 and 4 and undergo concurrent radiotherapy once or twice daily, 5 days a week, for 6 weeks. cisplatin : Given IV radiation therapy : Patients undergo radiation therapy once or twice daily, 5 days a week, for up to 7 weeks
- id
- BG001
- title
- Arm II
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 59
- group Id
- BG001
- value
- 66
- group Id
- BG002
- value
- 125
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 20
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9
- value
- 55
- group Id
- BG001
- spread
- 8
- value
- 54
- group Id
- BG002
- spread
- 8.4
- value
- 55
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 18
- title
- Female
- measurements
- group Id
- BG000
- value
- 64
- group Id
- BG001
- value
- 63
- group Id
- BG002
- value
- 127
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 138
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 7
- title
- Germany
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle